SCHEMBL6994073

SCHEMBL6994073

CC1Oc2ccc(CNCc3cccc(C(F)(F)F)c3)cc2NC1=O

nearest known ligand 0.73

Predicted protein targets (top 9)

geneUniProtsupporting neighboursconfidence
PARP1 P09874 9/20 0.73
EGFR P00533 1/20 0.42
HTT P42858 1/20 0.41
DAO P14920 2/20 0.40
DPP7 Q9UHL4 1/20 0.40
ALKBH5 Q6P6C2 1/20 0.40
FTO Q9C0B1 1/20 0.40
KDM4E B2RXH2 1/20 0.39
TDP1 Q9NUW8 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6305288 0.89 PARP1 (0.88) PARP1
SCHEMBL7000091 0.85 PARP1 (0.78) PARP1
SCHEMBL6310170 0.85 PARP1 (0.95) PARP1
SCHEMBL532477 0.85 PARP1 (1.00) PARP1
SCHEMBL6302991 0.85 PARP1 (0.90) PARP1
SCHEMBL6302733 0.83 PARP1 (0.78) PARP1
SCHEMBL6996295 0.83 PARP1 (0.78) PARP1HTT
SCHEMBL6305046 0.82 PARP1 (0.77) PARP1HTT
SCHEMBL6995652 0.82 PARP1 (0.80) PARP1
SCHEMBL6303081 0.82 PARP1 (0.80) PARP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1015437-B1 BENZOXAZINE AND BENZOTHIAZINE DERIVATIVES AND THEIR USE IN PHARMACEUTICALS SCHERING AG (DE) 2003-12-03 EP disclosed
US-6365736-B1 TREATMENT OF NERVOUS SYSTEM DISORDERS, CARDIOVASCULAR DISORDERS AND FOR ACTIVITY AS NO-SYNTHASES (NOS) INHIBITORS. SCHERING AKTIENGESELLSCHAFT (DE) 2002-04-02 US disclosed